Provisional Agenda
(Subject to change: The conference may finish earlier or later than the advertised time)
Event type: Virtual/in-person hybrid
Presentation language: English
Venue: The Jarvis Doctorow Hall, St Edmund Hall, Queen’s Lane, Oxford, UK
Time Zone: All times mentioned refer to British Standard (BST) – London/GMT +01:00.
Password and links: Registered conference delegates will be sent joining information and conference access links a few days before the conference.
World Time Converter: https://greenwichmeantime.com/time-gadgets/time-zone-converter | https://greenwichmeantime.com/timepiece/world-clock | https://www.worldtimebuddy.com
NB: Due to the hybrid nature of the agenda and the wide geographical locations of our speakers, it may not always be possible to group related presentations together.
Day 1, 26th August
1330: Registration
1430-1800: Presentations including refreshments
1830: Social event (TBC)
Day 2, 27th August
0900-1730: Presentations including lunch and refreshments
1915: Networking dinner (please check you email for further information)
Day 3, 28th August
0900 – 1230: Presentations including refreshments
1230: Discussion and close of the conference
Confirmed Speakers
Professor Sir David Warrell
Professor, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Snakebite species identification threatened by inexpert practice
Professor Cesare Montecucco
Professor Emeritus, Department of Biomedical Sciences, University of Padova and Institute of Neuroscience, National Research Council, Padova, Italy
Novel and simple methods to evaluate quantitatively respiration and peripheral neuroparalysis in mice poisoned by neurotoxic snake venoms without any animal manipulation
Professor Solange Serrano
Professor, Laboratory of Applied Toxinology, Center of Toxins, Immune-Response, and Cell Signaling (CeTICS), Butantan Institute, São Paulo, Brazil
Snake venom omics analyses: sharpening the understanding of various layers of complexity
Professor José María Gutiérrez
Professor, Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
A murine experimental model of the unique thrombotic effect induced by the venom of Bothrops lanceolatus
Professor Glenn King
Professor, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD, Australia
Deadly cures: a venom-inspired drug candidate for heart attack and heart transplantation
Professor Ana Maria Moura da Silva
Professor, Laboratório de Imunopatologia, Instituto Butantan, São Paulo, Brazil
Phenotypic dichotomy in Crotalus durissus ruruima venom and potential consequences for clinical management of snakebite envenomations
Professor Andreas Laustsen
Professor, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads, ongens Lyngby, Denmark
Protecting the human gut microbiota against pathogenic bacteria by neutralizing toxins and virulence factors with specific binding proteins
Professor Naoual Oukkache
Pasteur Institute of Morocco, Morocco
Development of humanized nanobodies targeting Naja haje neurotoxins: a promising complementary therapy for cobra envenomation
Professor Helena Safavi-Hemami, The University of Utah, USA
Professor Juan Calvete, Instituto de Biomedicina de Valencia, Spain
Dr David Williams, WHO, Switzerland
Dr Sebastien Duterte
Research Officer, IBMM, Université de Montpellier CNRS, ENSCM, Montpellier, France
Predatory vs defensive venom uses in cone snails: who cares, say the snakes
Dr Anne Ljungars
Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark
Oligoclonal nanobody-based recombinant antivenom for cobra, mamba, and rinkhals bites
Dr Tatiana Djikeussi
Premium Serums & Vaccines Pvt Ltd (PSVPL), Cameroon
A Post-Marketing Study on Safety and Efficacy of PANAF-Premium™ for Snakebite Envenomation in Northern Cameroon
Dr Susana Vazquez Torres
Postdoctoral Researcher, Department of Biochemistry, University of Washington, Seattle, WA, USA
De novo designed proteins neutralize lethal snake venom toxins
Dr Tihana Kurtović
Postdoctoral Researcher, Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Rockefellerova, Zagreb, Croatia
One antivenom, two paths: which administration route wins against venom?
Dr Sheikh Mohammed Arif
Postdoctoral Researcher, Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Rd, Cambridge, UK
Generating novel recombinant monoclonal antibodies targeting phospholipase A2 from spitting cobras
Dr Krisna Prak
Postdoctoral Researcher, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, UK
Snake venom L-amino acid oxidase induces mitochondria and lysosomal dysfunctions preventing autophagic flux and organelle clearance
Mr Sam Campbell
Graduate Research Student, Adaptive Biotoxicology laboratory, School of the Environment, The University of Queensland, Brisbane, Australia
Electrophysiological investigation of the relative efficacy of three antivenoms against medically significant Centruroides species
Dr Charlotte Dawson
Postdoctoral Researcher, Centre for Inflammation Research, Institute of Regeneration and Repair, University of Edinburgh, Edinburgh, UK
Establishing a preclinical chronic wound model to characterise the pathophysiology of snakebite envenoming
Miss Tian Du
Graduate Research Student, Charles Perkins Centre, The University of Sydney, NSW, Australia
A broad acting cnidaria venom antidote identified through whole genome CRISPR Screening
Miss Alexandra Sundman
Graduate Research Student, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD, Australia
Structure and mechanism of action of the lethal phospholipase D toxin from recluse spiders
Mr Lee Jones
Graduate Research Student, Adaptive Biotoxicology Lab, School of the Environment, University of Queensland, St Lucia, QLD, Australia
Ontogenetic variation in coagulotoxic activity and antivenom efficacy of Central American pit viper venoms (Cerrophidion, Metlapilcoatlus, Ophryacus and Porthidium)
Dr Rebecca Edge
Postdoctoral Researcher, Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK
The design and expression of a functional consensus P-I snake venom metalloproteinase
Dr David Eagles
Postdoctoral Researcher, Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland 4072, Australia
Development of a tarantula venom-derived peptide into a therapeutic for irritable bowel syndrome
More speakers will be announced soon!
